Lisanti Capital Growth’s Guardant Health GH Stock Holding History

Lisanti Capital Growth’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Buy	+10,610	New	+$1.15M	0.35%	95
2026 Q1	–	Sell	-38,665	Closed	-$3.95M	–	124
2025 Q4	$3.95M	Buy	+38,665	New	+$3.46M	0.94%	51
2025 Q2	–	Sell	-31,380	Closed	-$1.34M	–	121
2025 Q1	$1.34M	Buy	+31,380	New	+$1.35M	0.4%	85
2019 Q4	–	Sell	-19,270	Closed	-$1.23M	–	119
2019 Q3	$1.23M	Buy	19,270 +3,625	+23%	+$319K	0.4%	77
2019 Q2	$1.35M	Buy	+15,645	New	+$1.19M	0.44%	76

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Lisanti Capital Growth's GH Position: Q2 2026 in Review

Lisanti Capital Growth opened a new position in Guardant Health (GH) in Q2 2026: 10,610 shares worth $1.59M. The stake represents 0.35% of the portfolio and ranks #95 among its holdings. This is a return to the name: Lisanti Capital Growth previously reported a position in GH as recently as Q4 2025.

Lisanti Capital Growth first reported a position in GH in Q2 2019 and has held it in 5 quarters since. The position peaked at $3.95M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Lisanti Capital Growth held 10,610 shares of Guardant Health worth $1.59M as of Q2 2026.
Guardant Health was a new Lisanti Capital Growth position in Q2 2026.
Guardant Health made up 0.35% of Lisanti Capital Growth's portfolio in Q2 2026, its #95 holding.
Lisanti Capital Growth first reported a position in Guardant Health in Q2 2019 and has held it in 5 quarters since.
Lisanti Capital Growth's Guardant Health position peaked at $3.95M in Q4 2025.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.